Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2929-2026

GM Helix Implant, Endosseous Dental Implant Article No. 109.984 Recall

GM Helix Implant, Endosseous Dental Implant Article No. 109.984

FDA recall Class II

Ongoing

FDA lists this Class II recall for GM Helix Implant, Endosseous Dental Implant Article No. 109.984. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2929-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 13, 2026
FDA report date
Aug 19, 2026
Quantity in commerce
417 US
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

GM Helix Implant, Endosseous Dental Implant Article No. 109.984

Affected model & UDI checker

Search the exact identifiers published for Z-2929-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedGM Helix Implant, Endosseous Dental Implant Article No. 109.984Check source notice7899878024552
FDA code information

UDI-DI 7899878024552 Lot MVXJ9

View the original FDA recall notice

Why was this product recalled?

There may be a mismatch between the implant contained inside the packaging and the information described on the outer carton label. If the the incorrect implant is installed, the issue could cause bone compression or difficulty during installation in situations where there is sufficient bone volume

What actions did Straumann USA LLC take?

On July 13, 2026, the firm began notifying customers through a combination of mail, phone, and email. Letters were sent via overnight UPS delivery. Customers were instructed to check their inventory for the affected article/project numbers. If the product is still in inventory, customer should stop use or distribution immediately and quarantine/segregate physically. Product should be returned to Straumann USA, LLC for replacement. If the product has already been implanted, the firm states that implant removal is not required, and no additional patient follow up is required solely due to this recall.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology